Real‐World Effectiveness of Pegloticase Associated With Use of Concomitant Immunomodulatory Therapy

Documenti analoghi

• Treatment Sequencing and Line of Therapy for Biologics and JAK Inhibitors in Patients With Rheumatoid Arthritis: Implications for Design and Uptake of New Drugs and Predictive Biomarker Diagnostics
  di: Jeffrey R. Curtis, et al.
  Pubblicazione: (2026)
• Changes in Characteristics of Patients Initiating and Discontinuing Advanced Therapies for Rheumatoid Arthritis Following the Release of Safety Data
  di: Stephanie Song, et al.
  Pubblicazione: (2024)
• Financial Distress and Its Determinants in Rheumatoid Arthritis
  di: Amber Brown Keebler, et al.
  Pubblicazione: (2025)
• Gout Flares After Stopping Anti‐Inflammatory Prophylaxis: A Rapid Literature Review and Meta‐Analysis
  di: Lisa K. Stamp, et al.
  Pubblicazione: (2025)
• Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug
  di: Fenglong Xie, et al.
  Pubblicazione: (2026)